Edgewise Therapeutics, Inc. (EWTX)
30.85
-0.80
(-2.53%)
USD |
NASDAQ |
Mar 27, 16:00
30.82
-0.03
(-0.10%)
After-Hours: 20:00
Edgewise Therapeutics Free Cash Flow : -144.07M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Glaukos Corp. | -39.06M |
| Nuvalent, Inc. | -275.21M |
| Boston Scientific Corp. | 3.658B |
| Edwards Lifesciences Corp. | 1.335B |
| Eli Lilly & Co. | 5.964B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -38.59M |
| Cash from Investing (Quarterly) | 49.76M |
| Cash from Financing (Quarterly) | 3.975M |
| Free Cash Flow Per Share (Quarterly) | -0.3647 |
| Free Cash Flow to Equity (Quarterly) | -38.47M |
| Free Cash Flow to Firm (Quarterly) | -38.66M |
| Free Cash Flow Yield | -4.54% |